What animal models have taught us about the treatment of acute stroke and brain protection.

被引:9
作者
Ahmed S.H. [1 ]
Shaikh A.Y. [1 ]
Shaikh Z. [1 ]
Hsu C.Y. [1 ]
机构
[1] Department of Neurology, Washington University School of Medicine, Box 8111
基金
美国国家卫生研究院;
关键词
Cerebral Ischemia; Middle Cerebral Artery Occlusion; Acute Stroke; Acute Ischemic Stroke; Ischemic Brain;
D O I
10.1007/s11883-000-0112-2
中图分类号
学科分类号
摘要
Stroke research has progressed in leaps and bounds in the past decades. A driving force is the increasing availability of new research tools in this field (eg, animal stroke models). Animal stroke models have been extensively applied to advance our understanding of the mechanisms of ischemic brain injury and to develop novel therapeutic strategies for reducing brain damage after a stroke. Animal stroke models have been useful in characterizing the molecular cascades of injury processes. These "injury pathways" are also the targets of therapeutic interventions. The major achievements made in the past 2 decades applying animal stroke models include 1) the identification of the mediator role of excitotoxin and oxygen free radicals in ischemic brain injury; 2) the confirmation of apoptosis as a major mechanism of ischemic cell death; 3) the characterization of postischemic gene expression; 4) the delineation of postischemic inflammatory reaction; 5) the application of transgenic mice to confirm the roles of purported mediators in ischemic brain injury; 6) development of novel magnetic resonance imaging sequences for early noninvasive detection of ischemic brain lesions; and, 7) the development of novel therapeutic strategies based on preclinical findings derived from animal stroke models.
引用
收藏
页码:167 / 180
页数:13
相关论文
共 435 条
[1]  
Lee JM(1999)The changing landscape of ischaemic brain injury mechanisms Nature 399 A7-14
[2]  
Zipfel GJ(1998)Further evolution toward effective therapy for acute ischemic stroke JAMA 279 1298-1303
[3]  
Choi DW(1985)Tissue plasminogen activator reduces neurological damage after cerebral embolism Science 230 1289-1292
[4]  
Fisher M(1995)Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1581-1587
[5]  
Bogousslavsky J(1999)Effects of tissue plasminogen activator for acute ischemic stroke at one year: National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group N Engl J Med 340 1781-1787
[6]  
Zivin JA(1988)Why model strokes? Stroke 19 1195-1197
[7]  
Fisher M(1993)Criteria for valid preclinical trials using animal stroke models Stroke 24 633-636
[8]  
DeGirolami U(1994)Viability threshold and the penumbra of focal ischemia Ann Neurol 36 557-565
[9]  
Kwiatkowski TG(1996)Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J Cereb Blood Flow Metab 16 195-201
[10]  
Libman RB(1997)Inhibition of interleukin 1 beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage Proc Natl Acad Sci USA 94 2007-2012